Pasithea Therapeutics Corp.
Nasdaq KTTA · Miami Beach, FL
Works in Genetic & rare · Neurology · Oncology
Pasithea Therapeutics Corp. is a clinical trial sponsor based in Miami Beach, FL, listed as Nasdaq KTTA. It has 2 active clinical trials with 104 planned participants, in Genetic & rare, Neurology and Oncology.
Trial track record · since 2021
Financials · Nasdaq KTTA
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Pasithea Therapeutics Corp
Pasithea Therapeutics Corp is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 104 planned participants, in Genetic & rare, Neurology, Oncology. Since 2021 it has completed 0 trials and stopped 0 early.
Pasithea Therapeutics Corp is based in Miami Beach, FL and is listed as Nasdaq KTTA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Pasithea Therapeutics Corp; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-12-04.
Approve Suite is not affiliated with Pasithea Therapeutics Corp.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.